Literature DB >> 19155481

IL-12 enhances CTL synapse formation and induces self-reactivity.

Mary A Markiewicz1, Erica L Wise, Zachary S Buchwald, Elizabeth E Cheney, Ted H Hansen, Anish Suri, Saso Cemerski, Paul M Allen, Andrey S Shaw.   

Abstract

Immunological synapse formation between T cells and target cells can affect the functional outcome of TCR ligation by a given MHC-peptide complex. Although synapse formation is usually induced by TCR signaling, it is not clear whether other factors can affect the efficiency of synapse formation. Here, we tested whether cytokines could influence synapse formation between murine CTLs and target cells. We found that IL-12 enhanced synapse formation, whereas TGFbeta decreased synapse formation. The enhanced synapse formation induced by IL-12 appeared to be functional, given that IL-12-treated cells could respond to weak peptides, including self-peptides, to which the T cells were normally unresponsive. These responses correlated with expression of functionally higher avidity LFA-1 on IL-12-treated CTLs. These findings have implications for the function of IL-12 in T cell-mediated autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19155481      PMCID: PMC2630174          DOI: 10.4049/jimmunol.182.3.1351

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

1.  Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation.

Authors:  Mary A Markiewicz; Leonidas N Carayannopoulos; Olga V Naidenko; Ken Matsui; W Richard Burack; Erica L Wise; Daved H Fremont; Paul M Allen; Wayne M Yokoyama; Marco Colonna; Andrey S Shaw
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

2.  Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity.

Authors:  Michelle Krogsgaard; Qi-Jing Li; Cenk Sumen; Johannes B Huppa; Morgan Huse; Mark M Davis
Journal:  Nature       Date:  2005-02-20       Impact factor: 49.962

Review 3.  Guarding the immune system: suppression of autoimmunity by CD4+CD25+ immunoregulatory T cells.

Authors:  Tricia D Zwar; Ian R van Driel; Paul A Gleeson
Journal:  Immunol Cell Biol       Date:  2006-09-05       Impact factor: 5.126

Review 4.  Interleukin-12: biological properties and clinical application.

Authors:  Michele Del Vecchio; Emilio Bajetta; Stefania Canova; Michael T Lotze; Amy Wesa; Giorgio Parmiani; Andrea Anichini
Journal:  Clin Cancer Res       Date:  2007-08-15       Impact factor: 12.531

Review 5.  A very high level of crossreactivity is an essential feature of the T-cell receptor.

Authors:  D Mason
Journal:  Immunol Today       Date:  1998-09

6.  A mutant cell in which association of class I heavy and light chains is induced by viral peptides.

Authors:  A Townsend; C Ohlën; L Foster; J Bastin; H G Ljunggren; K Kärre
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1989

7.  Eradication of established tumors by CD8+ T cell adoptive immunotherapy.

Authors:  H L Hanson; D L Donermeyer; H Ikeda; J M White; V Shankaran; L J Old; H Shiku; R D Schreiber; P M Allen
Journal:  Immunity       Date:  2000-08       Impact factor: 31.745

8.  T cell receptor antagonist peptides induce positive selection.

Authors:  K A Hogquist; S C Jameson; W R Heath; J L Howard; M J Bevan; F R Carbone
Journal:  Cell       Date:  1994-01-14       Impact factor: 41.582

9.  The stimulatory potency of T cell antigens is influenced by the formation of the immunological synapse.

Authors:  Saso Cemerski; Jayajit Das; Jason Locasale; Phoebe Arnold; Emanuele Giurisato; Mary A Markiewicz; Daved Fremont; Paul M Allen; Arup K Chakraborty; Andrey S Shaw
Journal:  Immunity       Date:  2007-03-08       Impact factor: 31.745

10.  Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone.

Authors:  B Hemmer; B T Fleckenstein; M Vergelli; G Jung; H McFarland; R Martin; K H Wiesmüller
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

View more
  11 in total

1.  Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts.

Authors:  Sid P Kerkar; Pawel Muranski; Andrew Kaiser; Andrea Boni; Luis Sanchez-Perez; Zhiya Yu; Douglas C Palmer; Robert N Reger; Zachary A Borman; Ling Zhang; Richard A Morgan; Luca Gattinoni; Steven A Rosenberg; Giorgio Trinchieri; Nicholas P Restifo
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

Review 2.  IFN-γ: A cytokine at the right time, is in the right place.

Authors:  J Daniel Burke; Howard A Young
Journal:  Semin Immunol       Date:  2019-06-17       Impact factor: 11.130

3.  T cells and stromal fibroblasts in human tumor microenvironments represent potential therapeutic targets.

Authors:  Jennifer L Barnas; Michelle R Simpson-Abelson; Sandra J Yokota; Raymond J Kelleher; Richard B Bankert
Journal:  Cancer Microenviron       Date:  2010-03-31

4.  IL-12 Signals through the TCR To Support CD8 Innate Immune Responses.

Authors:  Nicholas P Goplen; Vikas Saxena; Karin M Knudson; Adam G Schrum; Diana Gil; Mark A Daniels; Rose Zamoyska; Emma Teixeiro
Journal:  J Immunol       Date:  2016-08-12       Impact factor: 5.422

5.  Differential regulation of effector- and central-memory responses to Toxoplasma gondii Infection by IL-12 revealed by tracking of Tgd057-specific CD8+ T cells.

Authors:  Douglas C Wilson; Gijsbert M Grotenbreg; Kenian Liu; Yanlin Zhao; Eva-Maria Frickel; Marc-Jan Gubbels; Hidde L Ploegh; George S Yap
Journal:  PLoS Pathog       Date:  2010-03-19       Impact factor: 6.823

6.  IL-12 and GM-CSF in DNA/MVA immunizations against HIV-1 CRF12_BF Nef induced T-cell responses with an enhanced magnitude, breadth and quality.

Authors:  Ana María Rodríguez; María Fernanda Pascutti; Cynthia Maeto; Juliana Falivene; María Pía Holgado; Gabriela Turk; María Magdalena Gherardi
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

Review 7.  Manipulating the TCR signaling network for cellular immunotherapy: Challenges & opportunities.

Authors:  Courtney A Matson; Nevil J Singh
Journal:  Mol Immunol       Date:  2020-05-15       Impact factor: 4.174

8.  Prostaglanin-E2 Potentiates the Suppressive Functions of Human Mononuclear Myeloid-Derived Suppressor Cells and Increases Their Capacity to Expand IL-10-Producing Regulatory T Cell Subsets.

Authors:  Sergej Tomić; Bojan Joksimović; Marina Bekić; Miloš Vasiljević; Marijana Milanović; Miodrag Čolić; Dragana Vučević
Journal:  Front Immunol       Date:  2019-03-18       Impact factor: 7.561

9.  An extrafollicular pathway for the generation of effector CD8(+) T cells driven by the proinflammatory cytokine, IL-12.

Authors:  Suhagi Shah; Gijsbert M Grotenbreg; Amariliz Rivera; George S Yap
Journal:  Elife       Date:  2015-08-05       Impact factor: 8.140

10.  Novel mucosal DNA-MVA HIV vaccination in which DNA-IL-12 plus cholera toxin B subunit (CTB) cooperates to enhance cellular systemic and mucosal genital tract immunity.

Authors:  Cynthia Maeto; Ana María Rodríguez; María Pía Holgado; Juliana Falivene; María Magdalena Gherardi
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.